Mito-magnolol compounds and methods of synthesis and use thereof
US11083739B2 · kind B2 · utility
0Cited by
0References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 13, 2019 |
| Grant date | Aug 10, 2021 |
| Priority date | — |
| Expiry date | Dec 13, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides mito-magnolol compounds, pharmaceutical compositions thereof, and methods of using the mito-magnolol compounds in the treatment of cancer, especially anti-cancer therapy or kinase resistant cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.